CHELCIE MURCH: Open Payments
NPI 1629752449 · AUBURN, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 37 payments from 18 companies in 2025. Trend: 2023 $101 · 2024 $543 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $168 |
| ABBVIE INC. | 3 | $94 |
| Novo Nordisk Inc | 4 | $72 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Dexcom, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $40 |
| PFIZER INC. | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Lundbeck LLC | 1 | $19 |
| Medtronic, Inc. | 1 | $17 |
Products named: BREZTRI, VRAYLAR, Auvelity, Dexcom G6 Transmitter, PAXLOVID, SHINGRIX, UBRELVY, AIRSUPRA.
Industry payments across ME — which companies pay providers there.
